Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
3179.00    95.00 (3.08%)
Bid:
3186.00
Ask:
3188.00
Spread: 2.00 (0.063%)
Market Cap: £4.43b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Third Quarter Trading Statement

27 Oct 2011 07:00

RNS Number : 9104Q
Croda International PLC
27 October 2011
 



27 October 2011

 

Croda International Plc

 

Third Quarter Trading Statement

 

Commenting on trading for the quarter ended 30 September 2011, Martin Flower, Chairman of Croda International Plc, said:

 

"I am pleased to report good turnover and profit progress in the third quarter, driven by sales growth and margin improvement in our core businesses.

 

For the three months ended 30 September 2011, Group sales from continuing operations increased 5.1% to £265.6m (2010: £252.6m). In most business areas we saw an improving trend during the quarter.

 

Operating profit from continuing operations increased 18.3% to £57.6m (2009: £48.7m). Interest costs fell, resulting in continuing pre-tax profit increasing 20.8% to £57.4m (2010: £47.5m).

Year-to-date, the pre-tax profit from continuing operations is up 27.1% at £182.2m (2010: £143.4m).

 

Consumer Care continued to trade strongly in the third quarter, reporting a significant increase in sales (+13.6%) and operating profit (+30.8%) and improved margins versus the corresponding quarter in 2010. Sales and operating profits in all business areas within Consumer Care were well ahead of 2010.

 

Industrial Specialities turnover declined 3.5% against the tough comparatives of a particularly strong third quarter in 2010. The shortfall was in July, with sales in the rest of the period ahead of 2010. Operating profit was down 6.8% with a decrease in commodity and by-product profitability being partially mitigated by stronger performances elsewhere in the sector.

 

Net debt reduced by £15.5m to £237.8m in the quarter (2010: £240.7m) despite completing the £50m buyback programme in the period.

 

Croda continues to trade well and we expect to report further progress in the final quarter and into 2012."

 

For further information please contact:

 

Mike Humphrey

Group Chief Executive

01405 860551

Sean Christie

Group Finance Director

01405 860551

Charlie Armitstead

FTI Consulting

020 7269 7176

 

 

The company will host a conference call for analysts at 8.00am today.

 

Please dial +44 (0)1452 562 815 and quote "Croda International" to gain access to the call.

 

Additional Information

 

 

 

 

 

£m

Q3

9 months

2011

2010

2011

2010

Consumer Care

145.6

128.2

+13.6%

439.2

392.6

+11.9%

Industrial Specialities

120.0

124.4

-3.5%

386.0

371.9

+3.8%

Continuing turnover

265.6

252.6

+5.1%

825.2

764.5

+7.9%

Consumer Care

42.5

32.5

+30.8%

130.5

103.6

+26.0%

Industrial Specialities

15.1

16.2

-6.8%

52.4

45.6

+14.9%

Continuing operating profit

57.6

48.7

+18.3%

182.9

149.2

+22.6%

Operating margin

 

21.6%

 

19.3%

 

 

 

22.2%

 

19.5%

 

 

 

Interest

(0.2)

(1.2)

(0.7)

(5.8)

Continuing pre tax profit

57.4

47.5

+20.8%

182.2

143.4

+27.1%

 

 

 

 

Analysis of Q3 turnover uplift

Price/mix

+18.4%

Volume

-14.8%

Currency translation

+1.5%

Continuing turnover increase

+5.1%

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTMFBATMBJTBIB
Date   Source Headline
6th Mar 201512:26 pmRNSDirector/PDMR Shareholding
5th Mar 20157:00 amRNSDirectorate Change
27th Feb 20153:15 pmRNSDirector/PDMR Shareholding
26th Feb 201511:51 amRNSDirector Declaration
24th Feb 20157:00 amRNSFinal Results
11th Feb 20152:36 pmRNSDirector/PDMR Shareholding
22nd Jan 201510:04 amRNSHolding(s) in Company
13th Jan 20153:18 pmRNSDirector/PDMR Shareholding
11th Dec 20145:07 pmRNSDirector/PDMR Shareholding
28th Nov 20142:55 pmRNSDirector/PDMR Shareholding
28th Nov 20147:00 amRNSDirector Declaration
28th Nov 20147:00 amRNSDirectorate Change
21st Nov 201410:09 amRNSDirector/PDMR Shareholding
19th Nov 20149:05 amRNSDirector/PDMR Shareholding
13th Nov 20143:17 pmRNSDirector/PDMR Shareholding
11th Nov 20142:13 pmRNSDirector/PDMR Shareholding
10th Nov 20145:31 pmRNSHolding(s) in Company
7th Nov 20144:07 pmRNSDirector/PDMR Shareholding
7th Nov 20147:00 amRNSInterim Management Statement
4th Nov 20148:33 amRNSDirector/PDMR Shareholding
21st Oct 20149:27 amRNSHolding(s) in Company
13th Oct 20145:26 pmRNSDirector/PDMR Shareholding
10th Oct 20147:00 amRNSDirectorate Change
2nd Oct 20142:43 pmRNSDirector/PDMR Shareholding
24th Sep 20145:48 pmRNSDirector/PDMR Shareholding
19th Sep 20144:00 pmRNSDirector/PDMR Shareholding
11th Sep 20143:02 pmRNSDirector/PDMR Shareholding
12th Aug 20143:20 pmRNSDirector/PDMR Shareholding
1st Aug 20149:23 amRNSDirector/PDMR Shareholding
24th Jul 201411:42 amRNSDirector/PDMR Shareholding
22nd Jul 201411:36 amRNSInterim Result 2014 - Replacement
22nd Jul 20147:00 amRNSInterim Results 2014
18th Jul 20149:21 amRNSHolding(s) in Company
14th Jul 20147:00 amRNSDirector/PDMR Shareholding
9th Jul 20149:39 amRNSHolding(s) in Company
30th Jun 20144:31 pmRNSDirector/PDMR Shareholding
30th Jun 201411:01 amRNSDirector/PDMR Shareholding
27th Jun 201410:33 amRNSDirector/PDMR Shareholding
26th Jun 201412:15 pmRNSHolding(s) in Company
24th Jun 20147:00 amRNSQ2 Pre-Close Trading Update
18th Jun 20147:00 amRNSSean Christie to step down as GFD in April 2015
11th Jun 20148:26 amRNSDirector/PDMR Shareholding
2nd Jun 20145:55 pmRNSDirector/PDMR Shareholding
29th May 20148:56 amRNSDirector/PDMR Shareholding
14th May 20149:22 amRNSDirector/PDMR Shareholding
13th May 20142:16 pmRNSDirector/PDMR Shareholding
8th May 201411:31 amRNSDirector/PDMR Shareholding
25th Apr 201410:45 amRNSHolding(s) in Company
24th Apr 20141:10 pmRNSResult of AGM
24th Apr 20147:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.